Editas Medicine IncNASDAQ:EDIT
- LAST PRICE10.9400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.0000/ 10
- Ask / Lots11.8000/ 23
- Open / Previous Close0.0000 / 10.9400
- Day Range---
- 52 Week Range
- Volume201
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EDIT |
|---|---|---|
| 09:32 ET | 54278 | 10.65 |
| 09:34 ET | 7959 | 10.745 |
| 09:36 ET | 16851 | 10.84 |
| 09:38 ET | 10406 | 10.97 |
| 09:39 ET | 14023 | 10.96 |
| 09:41 ET | 7490 | 10.8401 |
| 09:43 ET | 8111 | 10.75 |
| 09:45 ET | 14035 | 10.6001 |
| 09:48 ET | 18744 | 10.53 |
| 09:50 ET | 11472 | 10.4508 |
| 09:52 ET | 10873 | 10.45 |
| 09:54 ET | 10564 | 10.46 |
| 09:56 ET | 6005 | 10.54 |
| 09:57 ET | 10171 | 10.5799 |
| 09:59 ET | 3909 | 10.5 |
| 10:01 ET | 8901 | 10.58 |
| 10:03 ET | 8079 | 10.67 |
| 10:06 ET | 13893 | 10.74 |
| 10:08 ET | 3931 | 10.63 |
| 10:10 ET | 4697 | 10.5743 |
| 10:12 ET | 4916 | 10.6328 |
| 10:14 ET | 2266 | 10.57 |
| 10:15 ET | 5273 | 10.68 |
| 10:17 ET | 12196 | 10.83 |
| 10:19 ET | 7494 | 10.82 |
| 10:21 ET | 4301 | 10.88 |
| 10:24 ET | 1942 | 10.87 |
| 10:26 ET | 4620 | 10.79 |
| 10:28 ET | 4695 | 10.72 |
| 10:30 ET | 2413 | 10.74 |
| 10:32 ET | 8560 | 10.66 |
| 10:33 ET | 6575 | 10.74 |
| 10:35 ET | 2121 | 10.76 |
| 10:37 ET | 4400 | 10.68 |
| 10:39 ET | 7896 | 10.62 |
| 10:42 ET | 5394 | 10.59 |
| 10:44 ET | 5036 | 10.57 |
| 10:46 ET | 2193 | 10.63 |
| 10:48 ET | 2340 | 10.66 |
| 10:50 ET | 3645 | 10.63 |
| 10:51 ET | 2994 | 10.64 |
| 10:53 ET | 6209 | 10.76 |
| 10:55 ET | 6646 | 10.89 |
| 10:57 ET | 4945 | 10.84 |
| 11:00 ET | 5250 | 10.89 |
| 11:02 ET | 3484 | 10.92 |
| 11:04 ET | 8770 | 10.94 |
| 11:06 ET | 13521 | 10.87 |
| 11:08 ET | 4726 | 10.91 |
| 11:09 ET | 8967 | 10.9 |
| 11:11 ET | 10506 | 10.96 |
| 11:13 ET | 5214 | 10.9 |
| 11:15 ET | 1602 | 10.83 |
| 11:18 ET | 9966 | 10.78 |
| 11:20 ET | 3475 | 10.84 |
| 11:22 ET | 2670 | 10.84 |
| 11:24 ET | 12396 | 10.83 |
| 11:26 ET | 8223 | 10.85 |
| 11:27 ET | 4473 | 10.8501 |
| 11:29 ET | 1489 | 10.83 |
| 11:31 ET | 3347 | 10.88 |
| 11:33 ET | 2235 | 10.91 |
| 11:36 ET | 5941 | 10.92 |
| 11:38 ET | 7041 | 11.01 |
| 11:40 ET | 2638 | 11.04 |
| 11:42 ET | 29516 | 11.14 |
| 11:44 ET | 6169 | 11.18 |
| 11:45 ET | 7359 | 11.18 |
| 11:47 ET | 1700 | 11.19 |
| 11:49 ET | 3798 | 11.14 |
| 11:51 ET | 4206 | 11.11 |
| 11:54 ET | 3100 | 11.11 |
| 11:56 ET | 3116 | 11.12 |
| 11:58 ET | 2450 | 11.14 |
| 12:00 ET | 3117 | 11.15 |
| 12:02 ET | 5240 | 11.07 |
| 12:03 ET | 3947 | 11.07 |
| 12:05 ET | 4910 | 11.03 |
| 12:07 ET | 1600 | 11.06 |
| 12:09 ET | 4832 | 11.09 |
| 12:12 ET | 1100 | 11.15 |
| 12:14 ET | 2313 | 11.16 |
| 12:16 ET | 1560 | 11.17 |
| 12:18 ET | 2772 | 11.13 |
| 12:20 ET | 1514 | 11.09 |
| 12:21 ET | 4181 | 10.98 |
| 12:23 ET | 4670 | 10.9857 |
| 12:25 ET | 2669 | 11.01 |
| 12:27 ET | 1423 | 10.97 |
| 12:30 ET | 1686 | 11.01 |
| 12:32 ET | 2168 | 11.02 |
| 12:34 ET | 3138 | 11 |
| 12:36 ET | 3463 | 10.94 |
| 12:38 ET | 1233 | 10.91 |
| 12:39 ET | 600 | 10.89 |
| 12:41 ET | 8100 | 10.79 |
| 12:43 ET | 4280 | 10.811 |
| 12:45 ET | 4768 | 10.78 |
| 12:48 ET | 4157 | 10.79 |
| 12:50 ET | 8597 | 10.77 |
| 12:52 ET | 4268 | 10.83 |
| 12:54 ET | 3849 | 10.86 |
| 12:56 ET | 2827 | 10.83 |
| 12:57 ET | 2009 | 10.8824 |
| 12:59 ET | 1867 | 10.89 |
| 01:01 ET | 522 | 10.905 |
| 01:03 ET | 5307 | 10.87 |
| 01:06 ET | 2234 | 10.92 |
| 01:08 ET | 2093 | 10.9299 |
| 01:10 ET | 700 | 10.89 |
| 01:12 ET | 6800 | 10.82 |
| 01:14 ET | 2270 | 10.82 |
| 01:15 ET | 3289 | 10.8 |
| 01:17 ET | 2539 | 10.8 |
| 01:19 ET | 9578 | 10.88 |
| 01:21 ET | 1942 | 10.8401 |
| 01:24 ET | 2081 | 10.8939 |
| 01:26 ET | 1500 | 10.95 |
| 01:28 ET | 1915 | 10.905 |
| 01:30 ET | 984 | 10.88 |
| 01:32 ET | 2783 | 10.9 |
| 01:33 ET | 1902 | 10.99 |
| 01:35 ET | 3938 | 10.91 |
| 01:37 ET | 1163 | 10.9 |
| 01:39 ET | 1206 | 10.9 |
| 01:42 ET | 2933 | 10.89 |
| 01:44 ET | 3194 | 10.93 |
| 01:46 ET | 3425 | 10.93 |
| 01:48 ET | 2758 | 10.87 |
| 01:50 ET | 2569 | 10.78 |
| 01:51 ET | 3362 | 10.85 |
| 01:53 ET | 7108 | 10.9 |
| 01:55 ET | 3234 | 11 |
| 01:57 ET | 3262 | 11.06 |
| 02:00 ET | 6684 | 11.05 |
| 02:02 ET | 6825 | 10.96 |
| 02:04 ET | 3356 | 10.94 |
| 02:06 ET | 8786 | 10.97 |
| 02:08 ET | 1580 | 10.96 |
| 02:09 ET | 1833 | 10.98 |
| 02:11 ET | 8292 | 11.02 |
| 02:13 ET | 2914 | 10.98 |
| 02:15 ET | 993 | 11 |
| 02:18 ET | 2200 | 10.97 |
| 02:20 ET | 1999 | 10.96 |
| 02:22 ET | 2603 | 11.01 |
| 02:24 ET | 2366 | 11.02 |
| 02:26 ET | 1700 | 11.04 |
| 02:27 ET | 1326 | 11 |
| 02:29 ET | 2233 | 11.01 |
| 02:31 ET | 2460 | 11.03 |
| 02:33 ET | 4217 | 11.03 |
| 02:36 ET | 2350 | 11.025 |
| 02:38 ET | 3899 | 11.1 |
| 02:40 ET | 8328 | 11.09 |
| 02:42 ET | 4598 | 10.99 |
| 02:44 ET | 2267 | 11.01 |
| 02:45 ET | 3997 | 11.05 |
| 02:47 ET | 2066 | 11.05 |
| 02:49 ET | 1112 | 11.06 |
| 02:51 ET | 3199 | 11.04 |
| 02:54 ET | 1301 | 11.07 |
| 02:56 ET | 3400 | 11.11 |
| 02:58 ET | 4133 | 11.07 |
| 03:00 ET | 2545 | 11.12 |
| 03:02 ET | 6000 | 11.07 |
| 03:03 ET | 4100 | 11.105 |
| 03:05 ET | 3229 | 11.11 |
| 03:07 ET | 5687 | 11.1 |
| 03:09 ET | 4519 | 11.02 |
| 03:12 ET | 4863 | 11.04 |
| 03:14 ET | 3104 | 10.99 |
| 03:16 ET | 4713 | 10.98 |
| 03:18 ET | 8514 | 10.93 |
| 03:20 ET | 8512 | 10.89 |
| 03:21 ET | 2300 | 10.9 |
| 03:23 ET | 4292 | 10.86 |
| 03:25 ET | 2705 | 10.84 |
| 03:27 ET | 3793 | 10.82 |
| 03:30 ET | 4627 | 10.785 |
| 03:32 ET | 14570 | 10.76 |
| 03:34 ET | 7792 | 10.76 |
| 03:36 ET | 12542 | 10.74 |
| 03:38 ET | 8027 | 10.79 |
| 03:39 ET | 2701 | 10.775 |
| 03:41 ET | 6437 | 10.77 |
| 03:43 ET | 6788 | 10.825 |
| 03:45 ET | 11240 | 10.91 |
| 03:48 ET | 16763 | 10.885 |
| 03:50 ET | 5609 | 10.94 |
| 03:52 ET | 10877 | 10.835 |
| 03:54 ET | 6328 | 10.835 |
| 03:56 ET | 15058 | 10.875 |
| 03:57 ET | 21631 | 10.91 |
| 03:59 ET | 238171 | 10.94 |
May 18, 2022
Editas Medicine Presents Data on SLEEK Gene Editing Technology at the American Society of Gene and Cell Therapy Annual Meeting, from 6:45AM ET on Wednesday May 18, 2022 by GlobeNewswire
6:45AM ET on Wednesday May 18, 2022 by GlobeNewswire
May 13, 2022
Editas Medicine Gets FDA Orphan Drug Designation for Blood Disorder Candidate, from 4:31AM ET on Friday May 13, 2022 by MT Newswires
4:31AM ET on Friday May 13, 2022 by MT Newswires
May 12, 2022
BRIEF-Editas Medicine Receives FDA Orphan Drug Designation For Beta Thalassemia Treatment, from 4:41PM ET on Thursday May 12, 2022 by Thomson Reuters
4:41PM ET on Thursday May 12, 2022 by Thomson ReutersEditas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Beta Thalassemia, from 4:30PM ET on Thursday May 12, 2022 by GlobeNewswire
4:30PM ET on Thursday May 12, 2022 by GlobeNewswire
May 9, 2022
--Morgan Stanley Lowers Editas Medicine's Price Target to $15 From $17, Underweight Rating Kept, from 12:45PM ET on Monday May 09, 2022 by MT Newswires
12:45PM ET on Monday May 09, 2022 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Editas Medicine Inc | 735.8M | -4.0x | --- |
Mirum Pharmaceuticals Inc | 730.6M | -10.6x | --- |
CinCor Pharma Inc | 756.1M | 0.0x | --- |
IGM Biosciences Inc | 701.7M | -3.0x | --- |
Aclaris Therapeutics Inc | 793.7M | -8.8x | --- |
Merus NV | 688.5M | -8.6x | --- |
Company Information
Editas Medicine, Inc. is a clinical-stage gene editing company. The Company is focused on developing transformative gene editing medicines to treat a range of serious diseases. It has developed a gene editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or CRISPR from Prevotella and Francisella 1 (Cpf1), bound to a guide RNA molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. The Company is focused on both in vivo gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, and ex vivo gene-edited cell medicines, in which cells are edited with its technology. The Company's gene editing medicine programs include EDIT-101, EDIT-102, EDIT-103, EDIT-301 and EDIT-202.
Contact Information
- Headquarters
- 11 Hurley StCAMBRIDGE, MA, United States 02141-2110
- Phone
- 617-401-9000
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- James Mullen
- Chief Financial Officer, Executive Vice President
- Michelle Robertson
- Executive Vice President, Chief Scientific Officer
- Mark Shearman
- Executive Vice President, Chief Business Officer
- Bruce Eaton
- Senior Vice President, Chief Regulatory Officer
- Li Chi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $735.8M |
|---|---|
Revenue (TTM) | $25.8M |
Shares Outstanding | 68.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.09 |
EPS | $-2.73 |
Book Value | $8.09 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | 28.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -724.41% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
